Clinical Trial Update: Magnetic Resonance Spectroscopy Imaging in Predicting Response to Vorinostat and Temozolomide in Patients With Recurrent or Progressive Glioblastoma [NA]

View source ↗

Summary

A completed clinical trial evaluating magnetic resonance spectroscopy imaging to predict response to vorinostat and temozolomide in recurrent or progressive gli…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Temozolomide (Temozolomide)
• Vorinostat (vorinostat)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Adult Glioblastoma, Depression | NA | Status: COMPLETED | Results posted: 2014-06-11